The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
The PD-1/PD-Ls pathway and autoimmune diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
Nishimura, H., Nose, M., Hiai, H., Minato, N., & Honjo, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80089-8 · Cited by 2,749
PD-L1 regulates the development, maintenance, and function of induced regulatory T cells
Francisco, L. M., Salinas, V. H., Brown, K. E., Vanguri, V. K., Freeman, G. J., Kuchroo, V. K., & Sharpe, A. H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090847 · Cited by 2,079
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Chemnitz, J. M., Parry, R. V., Nichols, K. E., June, C. H., & Riley, J. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.945 · Cited by 1,246
Tissue expression of PD-L1 mediates peripheral T cell tolerance
Keir, M. E., Liang, S. C., Guleria, I., Latchman, Y. E., Qipo, A., Albacker, L. A., Koulmanda, M., Freeman, G. J., Sayegh, M. H., & Sharpe, A. H. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051776 · Cited by 1,211
CTLA-4–Ig regulates tryptophan catabolism in vivo
Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., et al. (2002) · Nature Immunology · doi:10.1038/ni846 · Cited by 1,161
The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice
Ansari, M. J. I., Salama, A. D., Chitnis, T., Smith, R. N., Yagita, H., Akiba, H., Yamazaki, T., Azuma, M., Iwai, H., Khoury, S. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022125 · Cited by 814
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
Fife, B. T., Pauken, K. E., Eagar, T. N., Obu, T., Wu, J., Tang, Q., Azuma, M., Krummel, M. F., & Bluestone, J. A. (2009) · Nature Immunology · doi:10.1038/ni.1790 · Cited by 759
Good-Jacobson, K. L., Szumilas, C. G., Chen, L., Sharpe, A. H., Tomayko, M. M., & Shlomchik, M. J. (2010) · Nature Immunology · doi:10.1038/ni.1877 · Cited by 691
Salama, A. D., Chitnis, T., Imitola, J., Ansari, M. J. I., Akiba, H., Tushima, F., Azuma, M., Yagita, H., Sayegh, M. H., & Khoury, S. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022119 · Cited by 506
Blansfield, J. A., Beck, K. E., Tran, K., Yang, J. C., Hughes, M. S., Kammula, U. S., Royal, R. E., Topalian, S. L., Haworth, L. R., Levy, C., et al. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000178913.41256.06 · Cited by 355
Frigola, X., Inman, B. A., Lohse, C. M., Krco, C. J., Cheville, J. C., Thompson, R. H., Leibovich, B., Blute, M. L., Dong, H., & Kwon, E. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0250 · Cited by 345
Lesterhuis, W. J., Punt, C. J. A., Hato, S. V., Eleveld-Trancikova, D., Jansen, B. J. H., Nierkens, S., Schreibelt, G., de Boer, A., Van Herpen, C. M. L., Kaanders, J. H., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43656 · Cited by 340
Role of PD-1 in Regulating T-Cell Immunity
Jin, H.-T., Ahmed, R., & Okazaki, T. (2010) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2010_116 · Cited by 305
Wang, S., Bajorath, J., Flies, D. B., Dong, H., Honjo, T., & Chen, L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021752 · Cited by 291
Bennett, F., Luxenberg, D., Ling, V., Wang, I.-M., Marquette, K., Lowe, D., Khan, N., Veldman, G., Jacobs, K. A., Valge-Archer, V. E., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.2.711 · Cited by 281
Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity
Gianchecchi, E., Delfino, D. V., & Fierabracci, A. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.05.003 · Cited by 270
Chen, Y., Wang, Q., Shi, B., Xu, P., Hu, Z., Bai, L., & Zhang, X. (2011) · Cytokine · doi:10.1016/j.cyto.2011.06.004 · Cited by 243
Self-citationWan, B., Nie, H., Liu, A., Feng, G., He, D., Xu, R., Zhang, Q., Dong, C., & Zhang, J. Z. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8844 · Cited by 233
PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo
Chikuma, S., Terawaki, S., Hayashi, T., Nabeshima, R., Yoshida, T., Shibayama, S., Okazaki, T., & Honjo, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900080 · Cited by 231
PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
Ghiotto, M., Gauthier, L., Serriari, N., Pastor, S., Truneh, A., Nunes, J. A., & Olive, D. (2010) · International Immunology · doi:10.1093/intimm/dxq049 · Cited by 229
Alternative splice variants of the human PD-1 gene
Nielsen, C., Ohm-Laursen, L., Barington, T., Husby, S., & Lillevang, S. T. (2005) · Cellular Immunology · doi:10.1016/j.cellimm.2005.07.007 · Cited by 226
The Programmed Death-1 Ligand 1:B7-1 Pathway Restrains Diabetogenic Effector T Cells In Vivo
Paterson, A. M., Brown, K. E., Keir, M. E., Vanguri, V. K., Riella, L. V., Chandraker, A., Sayegh, M. H., Blazar, B. R., Freeman, G. J., & Sharpe, A. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003496 · Cited by 202
Raptopoulou, A. P., Bertsias, G., Makrygiannakis, D., Verginis, P., Kritikos, I., Tzardi, M., Klareskog, L., Catrina, A. I., Sidiropoulos, P., & Boumpas, D. T. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27500 · Cited by 191
Kuipers, H., Muskens, F., Willart, M., Hijdra, D., van Assema, F. B. J., Coyle, A. J., Hoogsteden, H. C., & Lambrecht, B. N. (2006) · European Journal of Immunology · doi:10.1002/eji.200635978 · Cited by 191
Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection
Subudhi, S. K., Zhou, P., Yerian, L. M., Chin, R. K., Lo, J. C., Anders, R. A., Sun, Y., Chen, L., Wang, Y., Alegre, M.-L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19210 · Cited by 161
Soluble B7-H1: Differences in production between dendritic cells and T cells
Frigola, X., Inman, B. A., Krco, C. J., Liu, X., Harrington, S. M., Bulur, P. A., Dietz, A. B., Dong, H., & Kwon, E. D. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.11.001 · Cited by 146
He, Y., Zhang, G., Wang, X., Zhang, H., Yuan, Y., Li, D., & Feng, Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4919 · Cited by 138
Mechanisms of PDL1-mediated regulation of autoimmune diabetes
Guleria, I., Bupp, M. G., Dada, S., Fife, B. T., Tang, Q., Ansari, M. J., Trikudanathan, S., Vadivel, N., Fiorina, P., Yagita∥, H., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.05.013 · Cited by 130
PD-L2 is expressed on activated human T cells and regulates their function
Messal, N., Serriari, N., Pastor, S., Nunès, J. A., & Olive, D. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.06.436 · Cited by 122
Bertsias, G. K., Nakou, M., Choulaki, C., Raptopoulou, A., Papadimitraki, E. D., Goulielmos, G. N., Kritikos, H. D., Sidiropoulos, P. I., Tzardi, M. N., Kardassis, D., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24227 · Cited by 122
Greisen, S. R., Rasmussen, T., Stengaard‐Pedersen, K., Hetland, M. L., Hørslev‐Petersen, K., Hvid, M., & Deleuran, B. W. (2013) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2013.823517 · Cited by 111
Protective Role of Programmed Death 1 Ligand 1 (PD-L1)in Nonobese Diabetic Mice
Wang, C.-J., Chou, F., Chu, C.-H., Wu, J., Lin, S., Chang, D., & Sytwu, H. (2008) · Diabetes · doi:10.2337/db07-1260 · Cited by 105
Zhou, G., Zhang, J., Ren, X.-W., Hu, J., Du, G., & Xu, X.-Y. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9683-2 · Cited by 89
Kasagi, S., Kawano, S., Okazaki, T., Honjo, T., Morinobu, A., Hatachi, S., Shimatani, K., Tanaka, Y., Minato, N., & Kumagai, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901652 · Cited by 87
Mozaffarian, N., WIEDEMAN, A. E., & Stevens, A. M. (2008) · Rheumatology · doi:10.1093/rheumatology/ken256 · Cited by 83
Shi, B., Du, X., Wang, Q., Chen, Y., & Zhang, X. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.005 · Cited by 82
Self-citationGeng, H., Zhang, G., Han, X., Yuan, Y., Li, D., Zhang, H., Qiu, H., He, Y., & Feng, Z. (2006) · International Journal of Cancer · doi:10.1002/ijc.21795 · Cited by 81
He, X., Xu, L., & Liu, Y. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00086.x · Cited by 81
Programmed Death 1 Ligand (PD-L) 1 and PD-L2 Limit Autoimmune Kidney Disease: Distinct Roles
Weinmann‐Menke, J., Lucas, J. A., Zeller, G. C., Keir, M. E., Huang, X. R., Tsuboi, N., Mayadas, T. N., Lan, H. Y., Sharpe, A. H., & Kelley, V. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7466 · Cited by 81
TNF-α and TGF-β Counter-Regulate PD-L1 Expression on Monocytes in Systemic Lupus Erythematosus
Ou, J.-N., WIEDEMAN, A. E., & Stevens, A. M. (2012) · Scientific Reports · doi:10.1038/srep00295 · Cited by 77
Hamel, K. M., Cao, Y., Wang, Y., Rodeghero, R., Kobezda, T., Chen, L., & Finnegan, A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040690 · Cited by 74
Onlamoon, N., Rogers, K. A., Mayne, A. E., Pattanapanyasat, K., Mori, K., Villinger, F. J., & Ansari, A. A. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02766.x · Cited by 71
Kristjansdottir, H., Steinsson, K., Gunnarsson, I., Gröndal, G., Erlendsson, K., & Alarcón-Riquelme, M. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27417 · Cited by 70
Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-α
Hikita, A., Tanaka, N., Yamane, S., Ikeda, Y., Furukawa, H., Tohma, S., Suzuki, R., Tanaka, S., Mitomi, H., & Fukui, N. (2009) · Biochemistry and Cell Biology · doi:10.1139/o09-015 · Cited by 69
Amancha, P. K., Hong, J. J., Rogers, K. A., Ansari, A. A., & Villinger, F. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302044 · Cited by 68
Shin, S.-P., Seo, H.-H., Shin, J.-H., Park, H.-B., Lim, D. P., Eom, H., Bae, Y., Kim, I.-H., Choi, K., & Lee, S.-J. (2013) · Molecular Therapy · doi:10.1038/mt.2012.252 · Cited by 65
Han, X., Huang, B., Yuan, Y., Li, D., Han, L., Liu, Y., Gong, W., Wu, F., Zhang, G., & Feng, Z. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2154 · Cited by 65
The PD-1/PD-L1 Pathway in Human Pathology
Saresella, M., Rainone, V., Al‐Daghri, N. M., Clerici, M., & Trabattoni, D. (2012) · Current Molecular Medicine · doi:10.2174/156652412799218903 · Cited by 65
The effects of PDL-Ig on collagen-induced arthritis
Wang, G., Hu, P., Yang, J. L., Shen, G., & Wu, X. (2009) · Rheumatology International · doi:10.1007/s00296-009-1249-0 · Cited by 64
Elhag, O. A. O., Hu, X., Zhang, W., Xiong, L., Yuan, Y., Deng, L.-F., Liu, D., Liu, Y., & Hui, G. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.8.4031 · Cited by 61
Wang, X., Zhang, Z., Zhang, S., Fu, J., Yao, J., Jiao, Y., Wu, H., & Wang, F. (2008) · European Journal of Immunology · doi:10.1002/eji.200838285 · Cited by 60
CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1–Dependent Regulation of Type 1 Diabetes
Kadri, N., Korpos, É., Gupta, S., Briet, C., Löfbom, L., Yagita∥, H., Lehuen, A., Boîtard, C., Holmberg, D., Sorokin, L. M., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101390 · Cited by 58
Phenotypic and genetic analyses of T‐cell‐mediated immunoregulation in patients with Type 1 diabetes
Tsutsumi, Y., Jie, X., Ihara, K., Nomura, A., Kanemitsu, S., Takada, H., & Hara, T. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01951.x · Cited by 58
PD-L2 is predominantly expressed by Th2 cells
Lesterhuis, W. J., Steer, H. J., & Lake, R. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.014 · Cited by 52
Yoshida, T., Jiang, F., Honjo, T., & Okazaki, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710951105 · Cited by 51
Soluble PD-1 is Associated with Aberrant Regulation of T Cells Activation in Aplastic Anemia
Wu, H., Miao, M., Zhang, G., Hu, Y., Ming, Z., & Zhang, X. (2009) · Immunological Investigations · doi:10.1080/08820130902912332 · Cited by 46
Self-citationWong, M., Cava, A. L., Singh, R. P., & Hahn, B. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903401 · Cited by 44
Cloning and Identification of Two Novel Splice Variants of Human PD-L2
He, X., Liu, Y., Xu, L., & Zeng, Y.-Y. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.4.284 · Cited by 41
Pan, X., Li, L., MAO, J.-J., Yao, W., Zheng, J., Liu, M., & Fu, J. (2012) · Oncology Letters · doi:10.3892/ol.2012.966 · Cited by 33
Bishop, K. D., Harris, J. E., Mordes, J. P., Greiner, D. L., Rossini, A. A., Czech, M., & Phillips, N. E. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.01.008 · Cited by 30
Programmed Death-1: From gene to protein in autoimmune human myasthenia gravis
Sakthivel, P., Ramanujam, R., Wang, X. B., Pirskanen, R., & Lefvert, A. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.019 · Cited by 27
Wang, D., ZHOU, D., Du, Q., Liang, Q., Wang, Q., Li, F., Wang, G., FAN, Q., Liu, B., Zhou, J., et al. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1326 · Cited by 26
Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes
Won, T., Jung, Y. J., Kwon, S. J., Lee, Y. J., Lee, D. I., Min, H., Park, E. S., Joo, S. S., & Hwang, K. W. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1115-3 · Cited by 24
Xiao, L., Wang, D., Sun, C., Li, P., Jin, Y., Feng, L., & Chen, L. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27340 · Cited by 22
Kakoulidou, M., Wang, X., Zhao, X., Pirskanen, R., & Lefvert, A. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.01.007 · Cited by 20
Polymorphisms in PDCD1 gene are not associated with Wegener’s granulomatosis
Sakthivel, P., Giscombe, R., Ramanujam, R., & Lefvert, A. K. (2009) · Rheumatology International · doi:10.1007/s00296-009-0952-1 · Cited by 10
Cited by
PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations
Jiang, Y., Chen, M., Nie, H., & Yuan, Y. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1571892 · Cited by 640
Ralli, M., Angeletti, D., Fiore, M., D'Aguanno, V., Lambiase, A., Artico, M., de Vincentiis, M., & Greco, A. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102649 · Cited by 600
Liu, X., Ranganathan, R., Jiang, S., Fang, C., Sun, J., Kim, S., Newick, K., Lo, A., June, C. H., Zhao, Y., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2524 · Cited by 523
Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets
Tschoe, C., Bushnell, C. D., Duncan, P. W., Alexander-Miller, M. A., & Wolfe, S. Q. (2020) · Journal of Stroke · doi:10.5853/jos.2019.02236 · Cited by 490
Calderaro, J., Rousseau, B., Amaddeo, G., Mercey, M., Charpy, C., Costentin, C., Luciani, A., Zafrani, E., Laurent, A., Azoulay, D., et al. (2016) · Hepatology · doi:10.1002/hep.28710 · Cited by 440
Metadata
- Authors
- Dai, S., Jia, R., Zhang, X., Fang, Q., & Huang, L.
- Venue
- Cellular Immunology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 290
- Issue
- 1
- Pages
- 72-79
- ISSN
- 0008-8749 (ISSN-L)
- OpenAlex
- W2136683850
- Cited by
- 354
- References
- 70
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.